GRDN
Guardian Pharmacy Services Inc
$
28.490
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
28.970
Open
28.830
VWAP
28.52
Vol
241.06K
Mkt Cap
1.80B
Low
28.240
Amount
6.88M
EV/EBITDA(TTM)
--
Total Shares
63.32M
EV
1.83B
EV/OCF(TTM)
33.84
P/S(TTM)
1.30
Guardian Pharmacy Services, Inc. is a long-term care pharmacy services company. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.
Show More
2 Analyst Rating
Wall Street analysts forecast GRDN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GRDN is 30.00 USD with a low forecast of 30.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 28.490
Low
30.00
Averages
30.00
High
30.00
Current: 28.490
Low
30.00
Averages
30.00
High
30.00
Truist
David MacDonald
Buy
maintain
$28 -> $30
2025-09-26
Reason
Truist
David MacDonald
Price Target
$28 -> $30
2025-09-26
maintain
Buy
Reason
Truist analyst David MacDonald raised the firm's price target on Guardian Pharmacy to $30 from $28 and keeps a Buy rating on the shares. The firm remain bullish on Guardian post management meetings highlighting the company's strong positioning in a market with brisk core demand, overarching tailwinds and ongoing expansion opportunity, the analyst tells investors in a research note. Truist adds that Guardian's core trends remain strong, and the firm sees an attractive earnings power opportunity from recently acquired facilities.
Truist
Buy
maintain
$25 -> $28
2025-05-19
Reason
Truist
Price Target
$25 -> $28
2025-05-19
maintain
Buy
Reason
Raymond James
John Ransom
Outperform
maintain
$25 -> $28
2025-05-14
Reason
Raymond James
John Ransom
Price Target
$25 -> $28
2025-05-14
maintain
Outperform
Reason
Raymond James analyst John Ransom raised the firm's price target on Guardian Pharmacy to $28 from $25 and keeps an Outperform rating on the shares. The company's Q1 results were ahead of the firm's model on revenue, but $600,000 below on EBITDA due to some pull-forward on Heartland integration costs and a slight miss on seasonality, the analyst tells investors in a research note. This was a solid quarter with no major surprises outside of the small seasonality change, and Raymond James continues to like Guardian for its solid organic and inorganic growth potential, clean balance sheet with dry powder for M&A, and performance of operational execution.
Truist Securities
David Macdonald
Strong Buy
Maintains
$24 → $25
2025-04-11
Reason
Truist Securities
David Macdonald
Price Target
$24 → $25
2025-04-11
Maintains
Strong Buy
Reason
Truist analyst David MacDonald raised the firm's price target on Guardian Pharmacy to $25 from $24 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results in Healthcare Services and adjusting the firm's models. The sector looks relatively well positioned in a fluid environment given the scaled, largely domestic, attractive free cash flow generating, defensive nature of the group, and while regulatory developments remain an area of focus, the Medicare Advantage final rule reinforced the firm's expectation of a better environment, the analyst tells investors in a research note.
Truist Securities
David Macdonald
Strong Buy
Maintains
$22 → $24
2024-11-15
Reason
Truist Securities
David Macdonald
Price Target
$22 → $24
2024-11-15
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Guardian Pharmacy Services Inc (GRDN.N) is 29.89, compared to its 5-year average forward P/E of 24.51. For a more detailed relative valuation and DCF analysis to assess Guardian Pharmacy Services Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Overvalued
5Y Average PE
24.51
Current PE
29.89
Overvalued PE
27.27
Undervalued PE
21.74
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
14.80
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
16.23
Undervalued EV/EBITDA
13.37
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.88
Current PS
28.99
Overvalued PS
6.61
Undervalued PS
-2.85
Financials
Annual
Quarterly
FY2025Q2
YoY :
+35.86%
344.33M
Total Revenue
FY2025Q2
YoY :
-50.27%
12.58M
Operating Profit
FY2025Q2
YoY :
-63.89%
8.83M
Net Income after Tax
FY2025Q2
YoY :
-60.00%
0.14
EPS - Diluted
FY2025Q2
15.63M
Free Cash Flow
FY2025Q2
YoY :
-0.35%
19.79
Gross Profit Margin - %
FY2025Q2
YoY :
-53.53%
2.50
FCF Margin - %
FY2025Q2
YoY :
-73.44%
2.56
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
338.5M
USD
18
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
50.0K
Volume
1
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
338.5M
USD
18
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
GRDN News & Events
Events Timeline
2025-10-14 (ET)
2025-10-14
16:50:42
Guardian Pharmacy submits Form S-3 and lock-up agreements with pre-IPO investors.
2025-08-11 (ET)
2025-08-11
16:16:16
Guardian Pharmacy raises FY25 revenue view to $1.39B-$1.41B, consensus $1.35B
2025-08-11
16:15:33
Guardian Pharmacy reports Q2 adjusted EPS 23c, two estimates 22c
Sign Up For More Events
Sign Up For More Events
News
2.0
10-29NASDAQ.COMGRDN Surpasses Average Analyst Expectations
4.0
09-27NASDAQ.COMTruist Securities Upholds Buy Rating for Guardian Pharmacy Services (GRDN)
4.0
09-26BenzingaTruist Securities Reaffirms Buy Rating for Guardian Pharmacy Service and Increases Price Target to $30
Sign Up For More News
People Also Watch
FSLY
Fastly Inc
10.970
USD
+35.94%
OCSL
Oaktree Specialty Lending Corp
13.500
USD
-1.96%
ROOT
Root Inc
81.010
USD
-8.79%
WLFC
Willis Lease Finance Corp
123.710
USD
+2.66%
ELME
Elme Communities
16.570
USD
-0.48%
MRTN
Marten Transport Ltd
9.800
USD
-2.10%
AORT
Artivion Inc
47.500
USD
+2.13%
NYAX
Nayax Ltd
39.770
USD
-6.56%
JBGS
JBG SMITH Properties
18.110
USD
-3.52%
SABR
Sabre Corp
1.835
USD
-8.25%
FAQ
What is Guardian Pharmacy Services Inc (GRDN) stock price today?
The current price of GRDN is 28.49 USD — it has decreased -1.72 % in the last trading day.
What is Guardian Pharmacy Services Inc (GRDN)'s business?
What is the price predicton of GRDN Stock?
What is Guardian Pharmacy Services Inc (GRDN)'s revenue for the last quarter?
What is Guardian Pharmacy Services Inc (GRDN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Guardian Pharmacy Services Inc (GRDN)'s fundamentals?
How many employees does Guardian Pharmacy Services Inc (GRDN). have?